You have 9 free searches left this month | for more free features.

Cardiovascular Disease Risk

Showing 9951 - 9975 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19 Trial in Chicago (Tocilizumab)

Completed
  • COVID-19
  • Chicago, Illinois
    University of Chicago Medicine
May 13, 2022

Metastatic NSCLC Trial in Worldwide (Pembrolizumab, Lenvatinib, Docetaxel)

Active, not recruiting
  • Metastatic Non-Small Cell Lung Cancer
  • Pembrolizumab
  • +2 more
  • Bakersfield, California
  • +142 more
Sep 1, 2022

Blood Brain Barrier Defect, Sleep Deprivation, Sleep Apnea Trial in Berlin (Diagnostic Test)

Withdrawn
  • Blood Brain Barrier Defect
  • +3 more
  • Diagnostic Test
  • Berlin, Germany
    Charité Universitätsmedizin Berlin
Jul 25, 2022

Wheatgrass and Tulsi Formulation or Individuals Taken With Other

Not yet recruiting
  • Blood Pressure, High
  • +3 more
  • Observation study
  • Pune, Maharashtra, India
    Sinhgad college of Pharmacy
May 5, 2023

Angiotensin Converting Enzyme rs Gene Polymorphism and

Recruiting
  • Angiotensin Converting Enzyme rs (1799752) Gene Polymorphism and Development of In-Stent Restenosis in Patients With Stable Coronary Artery Diseases
  • DNA extraction AND Real- time polymerase chain reaction analysis to POLYMORPHISM OF in in-stent restenosis (ISR) in CAD
  • Sohag, Egypt
    Sohag university Hospital
Sep 20, 2023

MINOCA Trial in Bergen (CT coronary angiography and [12N] NH3 PET-MR)

Recruiting
  • MINOCA
  • CT coronary angiography and [12N] NH3 PET-MR
  • Bergen, Norway
    Department of Clinical Science, University of Bergen
Jan 3, 2023

Describe to Better Understand, Mealtime of People With

Not yet recruiting
  • Parkinson Disease
  • Deglutition Disorders
    • Toulouse, Haute-Garonne, France
      Centre Expert Parkinson
    May 31, 2023

    Allogeneic Stem Cell Transplant Candidate, Acute Myeloid/Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Cleveland

    Not yet recruiting
    • Allogeneic Stem Cell Transplant Candidate
    • +4 more
    • Cellular therapy product
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jul 1, 2022

    Obesity Trial in Atlanta (PATH Intervention, Control Group, Physical activity tracker)

    Not yet recruiting
    • Obesity
    • PATH Intervention
    • +3 more
    • Atlanta, Georgia
      Emory University
    Nov 7, 2023

    Parkinson Disease Trial in Ghent (Baseline assessment of demographic, anthropometric and clinical characteristics, Locomotor

    Active, not recruiting
    • Parkinson Disease
    • Baseline assessment of demographic, anthropometric and clinical characteristics
    • +3 more
    • Ghent, Belgium
    • +1 more
    Oct 20, 2021

    Emergencies Trial in Hangzhou (Aortic balloon assisted resuscitation, Traditional cardiopulmonary resuscitation, Esophageal

    Recruiting
    • Emergencies
    • Aortic balloon assisted resuscitation
    • +3 more
    • Hangzhou, Zhejiang, China
      Second Affiliated Hospital, Zhejiang University School of Medici
    Jun 28, 2021

    Lung Cancer Trial in Italy (Canakinumab, Placebo)

    Terminated
    • Lung Cancer
    • Rozzano, Milano, Italy, Italy
    • +5 more
    Feb 9, 2023

    COVID-19 Trial in France (Diagnostic test Covid-19)

    Completed
    • COVID-19
    • Diagnostic test Covid-19
    • Roubaix, France
    • +3 more
    May 9, 2022

    Endocarditis, Bacterial, Aneurysm, Intracranial Mycotic Trial (Brain MRI, digital subtraction angiography (DSA))

    Not yet recruiting
    • Endocarditis, Bacterial
    • Aneurysm, Intracranial Mycotic
    • Brain MRI
    • digital subtraction angiography (DSA)
    • (no location specified)
    Dec 7, 2021

    Patients With Chronic Obstructive Pulmonary Disease

    Recruiting
    • COPD
    • +2 more
    • Assessments of the sympathetic nerve activity axis
    • +4 more
    • Aachen, Germany
      RWTH Aachen University
    Oct 9, 2022

    Menopause, Atherosclerosis, Cardiovascular Diseases Trial in Helsinki (Estradiol, Placebo)

    Recruiting
    • Menopause
    • +3 more
    • Helsinki, Finland
      HUS Women's Hospital
    Feb 10, 2021

    Cardiovascular Diseases Trial in Belém (Physical exercise, monitoring)

    Completed
    • Cardiovascular Diseases
    • Physical exercise
    • monitoring
    • Belém, Pará, Brazil
      Universidade da Amazônia
    Aug 11, 2020

    Quantifying Body Composition and Liver Disease in Children Using

    Recruiting
    • NAFLD
    • NASH - Nonalcoholic Steatohepatitis
    • Magnetic resonance imaging (MRI)
    • +2 more
    • Los Angeles, California
      UCLA Medical Center
    Jan 5, 2022

    Healthy Aging Trial in Neuchâtel (Arm-in-arm gait training, Normal gait training)

    Recruiting
    • Healthy Aging
    • Arm-in-arm gait training
    • Normal gait training
    • Neuchâtel, Switzerland
      Haute-Ecole Arc Santé
    Jan 27, 2023

    Calciphylaxis : Population, Risk Factors, Diagnostic Practice,

    Completed
    • Calciphylaxis
    • Calcific Uremic Arteriolopathy
    • (no location specified)
    Sep 20, 2021

    Chronic Lymphocytic Leukemia (CLL) Trial

    Completed
    • Chronic Lymphocytic Leukemia (CLL)
      • (no location specified)
      Apr 5, 2022

      Healthy Trial in Busan (EB-203, Placebo)

      Recruiting
      • Healthy
      • Busan, Korea, Republic of
        Busan Paik Hospital, Inje University
      Sep 11, 2022

      Called FLAMINgO to Learn More About Treatment Combination of

      Active, not recruiting
      • Chronic Kidney Disease
      • Type 2 Diabetes
      • Finerenone (Kerendia, BAY94-8862)
      • Sodium-glucose cotransporter-2 inhibitors (SGLT2i)
      • Whippany, New Jersey
        Bayer
      Jan 19, 2023

      COVID-19, Virus Diseases, Corona Virus Infection Trial in Greece (Anakinra)

      Active, not recruiting
      • COVID-19
      • +3 more
      • Marousi, Athens, Greece
      • +26 more
      Jan 11, 2023

      Early Referral to Radiofrequency Ablation in Symptomatic Atrial

      Not yet recruiting
      • Atrial Fibrillation
      • Radiofrequency Ablation
      • Radiofrequency ablation
      • (no location specified)
      Sep 24, 2022